Intra-Cellular Therapies Statistics
Total Valuation
HKG:9901 has a market cap or net worth of HKD 57.32 billion. The enterprise value is 29.98 billion.
Market Cap | 57.32B |
Enterprise Value | 29.98B |
Important Dates
The last earnings date was Monday, July 28, 2025.
Earnings Date | Jul 28, 2025 |
Ex-Dividend Date | Sep 9, 2024 |
Share Statistics
Current Share Class | 1.64B |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.30% |
Shares Change (QoQ) | -1.38% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 114.65M |
Valuation Ratios
The trailing PE ratio is 19.66 and the forward PE ratio is 13.41.
PE Ratio | 19.66 |
Forward PE | 13.41 |
PS Ratio | 1.49 |
PB Ratio | 1.85 |
P/TBV Ratio | 2.06 |
P/FCF Ratio | n/a |
P/OCF Ratio | 8.15 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 10.29 |
EV / Sales | 0.78 |
EV / EBITDA | 4.52 |
EV / EBIT | 8.05 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.20.
Current Ratio | 1.58 |
Quick Ratio | 1.40 |
Debt / Equity | 0.20 |
Debt / EBITDA | 0.94 |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.39% and return on invested capital (ROIC) is 6.45%.
Return on Equity (ROE) | 9.39% |
Return on Assets (ROA) | 3.98% |
Return on Invested Capital (ROIC) | 6.45% |
Return on Capital Employed (ROCE) | 10.82% |
Revenue Per Employee | 565,611 |
Profits Per Employee | 42,905 |
Employee Count | 67,935 |
Asset Turnover | 0.64 |
Inventory Turnover | 25.14 |
Taxes
In the past 12 months, HKG:9901 has paid 1.15 billion in taxes.
Income Tax | 1.15B |
Effective Tax Rate | 28.02% |
Stock Price Statistics
The stock price has decreased by -37.26% in the last 52 weeks. The beta is 0.28, so HKG:9901's price volatility has been lower than the market average.
Beta (5Y) | 0.28 |
52-Week Price Change | -37.26% |
50-Day Moving Average | 38.43 |
200-Day Moving Average | 41.45 |
Relative Strength Index (RSI) | 32.81 |
Average Volume (20 Days) | 7,650,917 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 5.67 |
Income Statement
In the last 12 months, HKG:9901 had revenue of HKD 38.42 billion and earned 2.91 billion in profits. Earnings per share was 18.00.
Revenue | 38.42B |
Gross Profit | 21.30B |
Operating Income | 3.83B |
Pretax Income | 4.09B |
Net Income | 2.91B |
EBITDA | 4.67B |
EBIT | 3.83B |
Earnings Per Share (EPS) | 18.00 |
Balance Sheet
The company has 35.90 billion in cash and 6.30 billion in debt, giving a net cash position of 29.60 billion.
Cash & Cash Equivalents | 35.90B |
Total Debt | 6.30B |
Net Cash | 29.60B |
Net Cash Per Share | n/a |
Equity (Book Value) | 31.00B |
Book Value Per Share | 180.82 |
Working Capital | 14.88B |
Cash Flow
Operating Cash Flow | 7.03B |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 55.45%, with operating and profit margins of 9.97% and 7.59%.
Gross Margin | 55.45% |
Operating Margin | 9.97% |
Pretax Margin | 10.66% |
Profit Margin | 7.59% |
EBITDA Margin | 12.15% |
EBIT Margin | 9.97% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 1.36%.
Dividend Per Share | 0.47 |
Dividend Yield | 1.36% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | 2.30% |
Shareholder Yield | 3.66% |
Earnings Yield | 5.09% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on March 10, 2021. It was a forward split with a ratio of 10.
Last Split Date | Mar 10, 2021 |
Split Type | Forward |
Split Ratio | 10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 6 |